| PFISX | VFSAX | PFISX / VFSAX | |
| Total Expense Ratio | 1.04 | 0.16 | 650% |
| Annual Report Gross Expense Ratio | 1.05 | 0.16 | 656% |
| Fund Existence | 9 years | 7 years | - |
| Gain YTD | 3.736 | 9.718 | 38% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 330M | 14.3B | 2% |
| Annual Yield % from dividends | 2.79 | 2.95 | 95% |
| Returns for 1 year | 14.91 | 21.85 | 68% |
| Returns for 3 years | 44.46 | 45.47 | 98% |
| Returns for 5 years | 8.98 | 21.19 | 42% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CTCSX | 61.39 | 1.06 | +1.76% |
| Calamos Timpani Small Cap Growth C | |||
| SVAAX | 7.04 | N/A | N/A |
| Federated Hermes Strategic Value Div A | |||
| FMPFX | 42.20 | N/A | N/A |
| Nuveen Small Cap Growth Opp R6 | |||
| LYFIX | 16.56 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare I | |||
| OGINX | 53.01 | N/A | N/A |
| Invesco Global Opportunities R | |||